Acetylcysteine (Fresenius Kabi USA, LLC)
Welcome to the PulseAid listing for the Acetylcysteine drug offered from Fresenius Kabi USA, LLC. This Antidote [EPC],Antidote for Acetaminophen Overdose [EPC],Decreased Respiratory Secretion Viscosity [PE],Increased Glutathione Concentration [PE],Mucolytic [EPC],Reduction Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Fresenius Kabi USA, LLC |
NON-PROPRIETARY NAME: | ACETYLCYSTEINE |
SUBSTANCE NAME: | ACETYLCYSTEINE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Antidote [EPC],Antidote for Acetaminophen Overdose [EPC],Decreased Respiratory Secretion Viscosity [PE],Increased Glutathione Concentration [PE],Mucolytic [EPC],Reduction Activity [MoA] |
ROUTE: | ORAL; RESPIRATORY (INHALATION) |
DOSAGE FORM: | SOLUTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2012-09-01 |
END MARKETING DATE: | 0000-00-00 |
Acetylcysteine HUMAN PRESCRIPTION DRUG Details:
Item Description | Acetylcysteine from Fresenius Kabi USA, LLC |
LABELER NAME: | Fresenius Kabi USA, LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 200(mg/mL) |
START MARKETING DATE: | 2012-09-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 63323-690_2a60353b-9a4f-4bc8-8690-77ea688b7ea7 |
PRODUCT NDC: | 63323-690 |
APPLICATION NUMBER: | ANDA203853 |
Other ACETYLCYSTEINE Pharmaceutical Manufacturers / Labelers: